Lv2
138 积分 2025-07-03 加入
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)
1天前
待确认
Ofatumumab therapy modulates the meningeal lymphatic draining function in patients with multiple sclerosis: a pilot study
3天前
已完结
Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study
3个月前
已完结
Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders
4个月前
已完结
Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD
4个月前
已完结
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
7个月前
已完结
APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model
10个月前
已完结
Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder
10个月前
已完结
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
10个月前
已完结
Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
10个月前
已完结
皖公网安备34019202002308
